Similar to the IDP, the TAP supports the commercialization of advanced stage health technology through larger scale projects.
- Amount: 50% of project costs, with projects estimated at around $250,000-$1,500,000. Eligible costs include wages/salaries with benefits, direct R&D costs, commercialization and regulatory costs, and capital expenses. Funding is performance-based loans or convertible debentures.
- Timeline: Open.
- Eligibility: Must be an Ontario-based SME in the health sector trying to introduce a new technology or innovation.